Map1b Is Required for Axon Guidance and Is Involved in the Development of the Central and Peripheral Nervous System by Meixner, Arabella et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/2000/12/1169/10 $5.00
The Journal of Cell Biology, Volume 151, Number 6, December 11, 2000 1169–1178
http://www.jcb.org/cgi/content/full/151/6/1169 1169
 
MAP1B Is Required for Axon Guidance and Is Involved in the 
Development of the Central and Peripheral Nervous System
 
Arabella Meixner,* Silke Haverkamp,
 
‡
 
 Heinz Wässle,
 
‡
 
 Susanne Führer,
 
§
 
 Johann Thalhammer,
 
§
 
 
 
Nina Kropf,
 
i
 
 Reginald E. Bittner,
 
i 
 
Hans Lassmann,
 
¶
 
 Gerhard Wiche,* and Friedrich Propst*
 
*Institute of Biochemistry and Molecular Cell Biology, Vienna Biocenter, University of Vienna, A-1030 Vienna, Austria; 
 
‡
 
Department of Neuroanatomy, Max-Planck-Institute for Brain Research, D-60528 Frankfurt, Germany; 
 
§
 
University of 
 
Veterinary Medicine, A-1210 Vienna, Austria; and 
 
i
 
Neuromuscular Research Department and 
 
¶
 
Institute for Brain Research, 
University of Vienna, A-1090 Vienna, Austria
 
Abstract. 
 
Microtubule-associated proteins such as
 
MAP1B have long been suspected to play an impor-
tant role in neuronal differentiation, but proof has
been lacking. Previous MAP1B gene targeting studies
yielded contradictory and inconclusive results and did
not reveal MAP1B function. In contrast to two earlier
efforts, we now describe generation of a complete
MAP1B null allele. Mice heterozygous for this MAP1B
deletion were not affected. Homozygous mutants were
viable but displayed a striking developmental defect in
the brain, the selective absence of the corpus callosum,
and the concomitant formation of myelinated ﬁber
bundles consisting of misguided cortical axons. In addi-
tion, peripheral nerves of MAP1B-deﬁcient mice had a
reduced number of large myelinated axons. The myelin
sheaths of the remaining axons were of reduced thick-
ness, resulting in a decrease of nerve conduction veloc-
ity in the adult sciatic nerve. On the other hand, the
anticipated involvement of MAP1B in retinal develop-
 
ment and 
 
g
 
-aminobutyric acid C receptor clustering
was not substantiated. Our results demonstrate an es-
sential role of MAP1B in development and function of
the nervous system and resolve a previous controversy
over its importance.
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Introduction
 
Microtubule-associated protein (MAP)
 
1
 
 1B is one of the
first MAPs to be expressed during embryonic develop-
ment of the nervous system and the protein has long been
suspected to be instrumental in neuronal morphogenesis.
Expression can be detected in axons and growth cones as
early as day 14 of gestation (Fawcett et al., 1994). In addi-
tion, the protein can be phosphorylated by at least two ki-
nases implicated in neuronal development, cdk5 and GSK-
 
3
 
b
 
 (García-Pérez et al., 1998; Lucas et al., 1998) and is
differentially phosphorylated in distal axons and growth
cones (Black et al., 1994; Bush et al., 1996a). Finally, bio-
chemical and cell biological analyses have established that
MAP1B can bind not only to microtubules but also to ac-
tin filaments (Pedrotti and Islam, 1996; Tögel et al., 1998),
establishing MAP1B as a potential link between these two
components of the growth cone cytoskeleton.
MAP1B purified from mammalian brain constitutes a
multimeric protein complex that consists of one 300-kD
heavy chain and at least one 32-kD light chain, termed
LC1 (Hammarback et al., 1991). Both heavy chain and
LC1 are proteolytic cleavage products of a common
MAP1B polyprotein precursor that contains LC1 as a 250
amino acid–long carboxy-terminal segment (Hammarback
et al., 1991; Tögel et al., 1998, 1999). This MAP1B precur-
sor protein is encoded by a single gene consisting of seven
exons (Lien et al., 1994; Kutschera et al., 1998). However,
there exist multiple ways of transcription of this gene to
give rise to two types of transcripts (Lien et al., 1994; Kut-
schera et al., 1998). Type 1, the regular transcripts, repre-
 
sent the majority (
 
$
 
90%) of MAP1B mRNA and contain
exons 1-7. Type 2 transcripts (
 
#
 
10%) contain noncoding
exons upstream of exon 3 and potentially encode an
amino-terminally truncated MAP1B precursor lacking the
first 95 amino acids of the heavy chain.
In the past few years, several attempts have been made
to determine the role of MAP1B in brain development
through attenuation of MAP1B expression. However, the
results were contradictory. Early studies were carried out
in vitro and employed antisense oligonucleotide technol-
ogy. It was shown that MAP1B is necessary for the growth
of axons of PC12 cells and primary neurons in culture
(Brugg et al., 1993; DiTella et al., 1996). More recently,
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two gene-targeting studies were published that yielded
contradictory results. In the first, the MAP1B coding re-
gion was interrupted at codon 571 by insertion of a stop
codon (Edelmann et al., 1996). Mice homozygous for this
mutation died before day 10 of gestation. However, even
mice heterozygous for this mutation displayed severe neu-
rological phenotypes, raising the possibility that this domi-
nant phenotype was caused or enhanced by expression of
the 571 amino acid amino-terminal MAP1B fragment with
potential dominant-negative activity (Tögel et al., 1998)
encoded by the targeted allele. In contrast, in the second
MAP1B knockout study, mice homozygous for the muta-
tion were viable and showed only a slight retardation in
postnatal development (Takei et al., 1997). However, the
targeting strategy employed did not exclude the synthesis
of amino-terminally truncated MAP1B from alternative
transcripts (Kutschera et al., 1998). Indeed, a protein reac-
tive with three anti–MAP1B antibodies and slightly
smaller than authentic MAP1B was still detected in brain
extracts of homozygous mutants (Takei et al., 1997). Thus,
the lack of severe phenotypes in these mice might be due
to residual MAP1B expression that might be sufficient for
proper albeit retarded development.
Here we generated a true null allele of MAP1B by intro-
ducing a large deletion in the gene that led to complete abla-
tion of MAP1B expression and prevented synthesis of
amino-terminal MAP1B fragments. This allowed us for the
first time to assess the effect of MAP1B deficiency in vivo. In
contrast to the previous inconclusive and contradictory re-
sults, we found that MAP1B is essential for the development
and function of the nervous system and is involved in axon
guidance of a subset of neurons. We also ruled out an ex-
pected essential function of MAP1B in retina development.
 
Materials and Methods
 
Gene Targeting
 
All experiments involving animals were performed in accordance with
Austrian Federal Government laws and regulations. The targeting vector
was constructed by joining a 4-kb BamHI/KpnI fragment located just up-
stream of exon 3 and a 2.3-kb SacII/XhoI fragment spanning intron 5 of the
mouse MAP1B genomic locus (Kutschera et al., 1998) as the 5
 
9
 
 and 3
 
9
 
 ho-
mologous arms, respectively, to a thymidine kinase promoter driven neo
cassette (provided by M. Kraus, Institute for Genetics, University of Co-
logne, Cologne, Germany) in reverse transcriptional orientation (see Fig. 1
A). The linearized targeting vector was electroporated into embryonic
stem cells of lines R1 and E14.1 derived from different substrains of mouse
strain 129 (Simpson et al., 1997; Threadgill et al., 1997), and G418-resistant
colonies of cells heterozygous for the correctly targeted allele were isolated
(Hogan et al., 1994) and identified by Southern blot analysis (Sambrook et
al., 1989). Germ line chimeras were obtained as described (Hogan et al.,
1994) and bred to C57BL/6 females to obtain F1 mice heterozygous for the
MAP1B deletion. All results shown here were obtained with F2 and F3 off-
spring of F1 heterozygotes derived from targeted R1 stem cells. Genotyp-
ing of offspring was performed by Southern blot analysis of tail DNA by di-
gestion with EcoRV and hybridization to an exon 7 probe (see Fig. 1)
labeled using the AlkPhos Direct™ labeling kit (Amersham Pharmacia
Biotech) according to the manufacturer’s recommendations.
 
Protein Analysis
 
For protein expression analysis, freshly collected or frozen tissues were
homogenized at 100 mg/ml in a buffer containing 8 M urea, 4% SDS, 150
mM Tris-HCl, pH 6.8, 12 mM EDTA, 0.3% DTT, 10 
 
m
 
M benzamidine, 1
mM PMSF, 2 
 
m
 
M pepstatin, 2 
 
m
 
M aprotinin, 2 
 
m
 
M leupeptin, 20% (vol/
vol) glycerol, and 0.002% bromphenol blue with a PT 3000 Kinematica
homogenizer. Samples were centrifuged at 10,000 
 
g
 
 for 5 min at 4
 
8
 
C. The
 
supernatants were sonicated, centrifuged again, and incubated at 65
 
8
 
C for
10 min. Aliquots were analyzed by SDS-PAGE and immunoblotting was
performed as described (Sambrook et al., 1989).
A rabbit polyclonal anti–heavy chain antiserum termed E2 was raised
against the synthetic peptide CETVTEEHLRRAIGN (mouse MAP1B
exon 2 encoded amino acids 45–58 linked to an amino-terminal cysteine;
Gramsch Laboratories), affinity purified as described (Tögel et al., 1998),
and used at a dilution of 1:1,000. Other antibodies: anti–MAP1B heavy
chain mAb MAP5 clone AA-6 (1:1000; Boehringer), affinity purified
polyclonal rabbit anti–MAP1B light chain antibody (1 
 
m
 
g/ml; Tögel et al.,
1998), anti–MAP1A heavy chain mAb HM-1 (1:500; Biogenesis), poly-
clonal rabbit anti–MAP1A light chain serum raised against the synthetic
peptide CKGPVDRTSRTVPRPR (rat MAP1A amino acids 2605–2619
linked to an amino-terminal cysteine; 1:1,000), anti–MAP2 mAb HM-2
(1:800; Sigma-Aldrich), anti–tau mAb TAU1 (1:1,000; Boehringer), anti–
light chain 3 polyclonal rabbit antibody (1:2,500; provided by J. Ham-
marback, Wake Forest University, School of Medicine, Department of
Neurobiology and Anatomy, Winston Salem, NC), and anti–
 
a
 
-tubulin
mAb B-5-1-2 (1:800; Sigma-Aldrich). Alkaline phosphatase-conjugated
goat anti–rabbit and anti–mouse antibodies (1:7,500; Promega) were used
as secondary antibodies.
 
Histopathology, Immunocytochemistry, Electron 
Microscopy, and Histomorphometry
 
1-d-old mice were anesthetized with ether, the bodywall was opened, and
the animals were fixed overnight in 4% paraformaldehyde in PBS, pH 7.4.
Older animals were perfused intracardially with 4% paraformaldehyde in
PBS. Brains and spinal cords were dissected out, fixed overnight in 4%
paraformaldehyde in PBS, and routinely embedded in paraffin. 5-
 
m
 
m-
thick paraffin sections were stained with hematoxylin/eosin, Luxol fast
blue myelin stain, and Bielschowski Silver impregnation for axons. Immu-
nocytochemistry was performed on paraffin sections with antibodies
against glial fibrillary acidic protein (Boehringer) and the macrophage an-
tibody Mac-3 (PharMingen). Binding of primary antibodies was visualized
with a biotin-avidine-peroxidase technique. For electron microscopy, ani-
mals were perfused with 3% glutaraldehyde in 0.1 M phosphate buffer.
Small tissue blocks of brain (corpus callosum, optic nerve, and cerebel-
lum) or sciatic nerve were impregnated in 1% osmic acid and routinely
embedded in epoxy resin. 0.5-
 
m
 
m-thick plastic sections were cut on a
Reichert Ultracut and stained with toluidine blue. Ultrathin sections were
viewed in a Jeol 1010 electron microscope.
For histomorphometric analysis of Toluidin blue–stained semithin sec-
tions of sciatic nerves of MAP1B deficient (
 
n
 
 
 
5 
 
5, aged 8–11 mo) and
wild-type mice (
 
n
 
 
 
5 
 
3, aged 8–11 mo) the DIGI-2000 software (version
3.0) was used. The amount of endoneural connective tissue was assessed
by subtraction of the sum total of neuronal structures from the entirely as-
sessed cross-sectional area of the respective histological sample. Evalua-
tion of myelin thickness was achieved by subtracting the maximal inner
from the maximal outer diameters of the myelin sheaths. Every axon in
the elected field was counted, regardless of its size. For the statistical eval-
uation, groups of sizes were deliberately chosen to achieve a histogram
representing the fiber sizes. Statistical significance of the differences of (a)
axon diameters/areas and (b) thickness of the myelin sheaths between
wild-type animals and MAP1B 
 
2
 
/
 
2
 
 mice were tested using the Kolmog-
oroff-Smirnoff test and Student’s 
 
t
 
 test. Additionally, the correlation coef-
ficient was calculated for a possible association between axon diameters/
areas versus the myelin sheaths thickness.
For analysis of retinae, wild-type mice and mice heterozygous or ho-
mozygous for the MAP1B deletion of different ages (P18, P47, and P108)
were killed by cervical dislocation, the eyes were enucleated, the anterior
segments removed, and the posterior eyecups immersion fixed for 15–25
min in 4% paraformaldehyde in phosphate buffer (PB, 0.1 M, pH 7.4). Af-
ter fixation, the retinae were dissected from the eyecup, cryoprotected in
graded sucrose solutions (10, 20, and 30%), and sectioned vertically at 12
 
m
 
m on a cryostat. Retinal sections were blocked for 1 h in a solution con-
taining 10% normal goat serum (NGS), 1% bovine serum albumin, and
0.5% Triton-X-100 in PB. MAP1B was detected using the monoclonal an-
tibody MAP5 (Sigma-Aldrich) or the affinity purified polyclonal rabbit
anti–MAP1B light chain antibody (Tögel et al., 1998). 
 
g
 
-Aminobutyric
acid C (GABA
 
C
 
) receptor subunits were detected using a rabbit anti–
serum (Enz et al., 1996). All primary antibodies were diluted 1:100 in 3%
NGS, 1% BSA, 0.05% Triton-X-100 in PB, and applied overnight at room
temperature. After washing in PB, secondary antibodies were applied for
1 h. These included: goat anti–mouse or anti–rabbit IgG conjugated to Al-
exa TM 488 (Molecular Probes), diluted 1:500. Control experiments with 
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omitting primary antisera resulted in unspecific background staining. All
fluorescent specimens were viewed using an Axiophot microscope (Carl
Zeiss, Inc.). Micrographs were taken with a cooled CCD camera (Spot2;
Diagnostic Instruments) and processed using Adobe Photoshop 5.0.1.
 
Behavioral Tests and Electrophysiology
 
F1 male mice heterozygous or homozygous for the targeted MAP1B allele as
well as wild-type controls were placed into a macrolite cage and observed for
10 min for their activity, exploring behavior, and ataxia. The different pat-
terns were quantified by normal or abnormal activity, normal or abnormal
exploring, and normal gait or ataxia, as described (Thalhammer et al., 1995).
Motor nerve conduction velocities were studied in the sciatic nerve in
wild-type controls and in homozygous MAP1B mutant animals. For this
procedure, animals were anaesthetized by i.p. injection of 60 mg/kg sodium
pentobarbital and placed on a water-circulated heating pad throughout the
procedure. The nerve was stimulated with percutaneous electrodes by su-
pramaximal stimulation at the sciatic notch (Waikar et al., 1996) and sum-
mation motor potentials were recorded with a ring electrode at the metacar-
pus. The ground electrode was placed between stimulation and recording
sites. After the procedure, the animals recovered spontaneously.
 
Results
 
General Characteristics of MAP1B-deficient Mice
 
To obtain true MAP1B-deficient mice, we generated a null
allele termed MAP1B
 
D
 
93 harboring a deletion of 20.5 kb of
chromosomal DNA. The deletion included coding exons
3–5 and part of exon 6 (Fig. 1 A), comprising 93% of the
MAP1B coding sequence (codons 96–2389 of a total of
2,464 codons) and was designed to preclude synthesis of
MAP1B from regular as well as alternative transcripts (Kut-
schera et al., 1998). Thus, MAP1B
 
D
 
93 differed from the al-
lele generated by Takei et al. (1997), which carried merely a
truncation of exon 1 that did not prevent synthesis of
MAP1B from alternative transcripts and from the allele
generated by Edelmann et al. (1996) in that it could not en-
code a large amino-terminal fragment of the heavy chain.
Consistent with the extent of the deletion in the MAP1B
gene, neither transcripts containing exon 5 sequences (not
shown) nor MAP1B heavy or light chain polypeptides (Fig. 1,
C and D) were detectable in brains of newborn mice ho-
mozygous for MAP1B
 
D
 
93. This confirmed that MAP1B
 
D
 
93
represented a true null allele incapable of encoding MAP1B
heavy or light chain from regular or alternative transcripts.
Moreover, we failed to detect an amino-terminal MAP1B
fragment potentially encoded by exons 1 and 2 of the tar-
geted allele (Fig. 1 E). Analysis of the level of expression of
MAP2A, MAP2B, MAP2C, tau, MAP1A (heavy and light
chain), and light chain 3, a 30-kD polypeptide that forms
complexes with MAP1B and MAP1A (Schoenfeld et al.,
1989) did not reveal consistent alterations in MAP1B-defi-
cient mice (Fig. 2). Apparent minor changes observed in indi-
 
vidual experiments were not manifest when normalized with
respect to the intensity of the corresponding tubulin bands.
Thus, MAP1B deficiency was not compensated for by in-
creased expression of other brain-specific MAPs.
Mice heterozygous for MAP1B
 
D
 
93 were indistinguish-
able in appearance from their wild-type littermates. In con-
trast, almost all homozygous pups (94%) displayed severe
reduction in body weight that was more pronounced in the
first 4 wk of life, in particular in the case of females (Table
I). This reflected the fact that the weakest animals died
during this time (Table II), with only the stronger animals
displaying less severe weight reduction surviving into
adulthood. The cause of this general weakness and body
weight reduction is not known at this point. Homozygous
pups appeared malnourished and dehydrated and showed
a delay in body hair growth and eye-lid opening. However,
not even the weakest, moribund animals had obvious neu-
rological problems or pathological alterations (apart from
the developmental defects in the brain, which were also
found in those homozygous mutants that survived into
adulthood, see below) that could explain their condition.
Adult homozygous males and females were fertile, but
were poor breeders. Quantitative assessment of activity,
exploring activity, and ataxia revealed that exploring activ-
ity was absent in almost all homozygous MAP1B mutants
(Fig. 3), whereas general activity and gait appeared nor-
mal. All phenotypic alterations observed in MAP1B 
 
2
 
/
 
2
 
mice, including the reduction in body weight and each of
the defects found in the nervous system (described below),
occurred in 94–100% of mice homozygous for the MAP1B
deletion and were never observed in heterozygotes or
wild-type controls. Only a small percentage of homozygous
mutants (3/52, 6%) did not show any abnormalities.
 
Retinal Development and GABA
 
C
 
 Receptor Clustering 
Are Not Impaired in MAP1B-deficient Mice
 
Almost all MAP1B-deficient mice (94%) displayed uni- or
bilateral abnormalities of their eyes in that the eyes ap-
peared smaller or retracted despite eyeballs of normal
size. A similar phenotype was observed in more than half
of homozygous MAP1B mutants in one of the previous
gene-targeting studies (Takei et al., 1997). In contrast,
Edelmann et al. (1996) reported gross deformation of ocu-
lar orbs in heterozygous MAP1B mutants and attributed
apparent blindness of heterozygotes to disorganization of
the retina. Further evidence for a role of MAP1B in retinal
development came from the finding that MAP1B binds to
a retina-specific GABA
 
C
 
 receptor subunit (Hanley et al.,
1999). Therefore, we reexamined retinal structure and
GABA
 
C
 
 receptor clustering in detail in the true MAP1B
null mice homozygous for MAP1B
 
D
 
93.
 
Table I. Body Weight of Wild-Type and MAP1B Mutant Mice
 
Age Sex Wild type Heterozygotes Homozygotes*
Weight 
reduction
 
w k gngngn %
 
3 male 11.6 
 
6
 
 2.3 11 10.3 
 
6
 
 1.7 14 6.9 
 
6
 
 2.3 11 33
3 female 11.1 
 
6
 
 1.4 9 11.1 
 
6
 
 1.7 12 4.9 
 
6
 
 0.7 6 56
8 male 28.1 
 
6
 
 2.5 15 28.4 
 
6
 
 1.7 24 20.1 
 
6
 
 0.9 9 29
8 female 22.8 
 
6
 
 2.3 7 22.9 
 
6
 
 1.2 9 19.4 
 
6
 
 1.6 6 15
 
*Different from the value of wild-type and heterozygous control mice at 
 
P
 
 
 
,
 
 0.001 as
determined by Student’s
 
 t
 
 test.
 
Table II. Postnatal Lethality of MAP1B-deficient Mice
 
Number of progeny
 
1
 
/
 
11
 
/
 
22
 
/
 
2
 
%% %
 
Total born 61 25 140 55 52 20
Adult male 27 68 18
Adult female 32 67 5
Postnatal lethality 2 3.3 5 3.6 29 55.8 
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Figure 1. Deletion of 93% of the coding region of the mouse chromosomal MAP1B locus leads to MAP1B heavy- and light-chain defi-
ciency. (A) Schematic of the targeting strategy. MAP1B coding exons present in regular transcripts are indicated by filled boxes, noncod-
ing exons (IIIA and IIIU) present in alternative transcripts by open boxes. Exons are numbered (I–VII). Relevant restriction sites, ATG
start codons for regular transcripts (exon I), and alternative transcripts (exons IV and V), the heavy chain–light chain cleavage site of the
polyprotein precursor, the TGA stop codon, as well as the position of the exon VII probe are indicated. The EcoRV restriction sites of the
wild-type and targeted alleles that were used for diagnostic digests are marked (*). The horizontal arrow above the neo cassette indicates
the direction of its transcription. For better visibility, the small MAP1B exons and the neo cassette are drawn disproportionately long. (B)
Southern blot analysis of tail DNA of wild-type (1/1), heterozygous (1/2), and homozygous (2/2) MAP1B mutant mice using EcoRV
and the exon VII probe. The diagnostic EcoRV fragments of the wild-type and targeted allele are 11.5 and 9 kb, respectively. Immunoblot
analysis of MAP1B expression. 80 mg of total protein extracted from brains of 1-d-old wild-type (1/1), heterozygous (1/2) or homozy-
gous (2/2) MAP1B mutant mice were fractionated on 7.5% (C) or 12% (D) gels. Blots were incubated with monoclonal antibody MAP5
(C) or polyclonal anti–light-chain antibody (D) to detect heavy chain (HC) and light chain (LC1), respectively. Tubulin (Tb) detected on
the same blots with antitubulin antibodies served as internal control. The LC1 doublet detected in wild-type and heterozygous mice was
seen consistently and might be due to post-translational modification of the light chain. (E) Immunoblot analysis of expression of an
amino-terminal MAP1B fragment potentially encoded by the targeted allele. 80 mg of total protein extracted from brains of 1-d-old wild-
type (1/1) or homozygous (2/2) MAP1B mutant mice were fractionated on a 6% gel. Expression of the heavy chain (HC) was analyzed
using the monoclonal antibody MAP5 and an affinity purified polyclonal rabbit antipeptide antibody (E2) directed against mouse MAP1B
amino acids 45–58 encoded by exon 2 as indicated. Both antibodies detected a protein band of the same size in wild-type but not mutant
mice, demonstrating that the antipeptide antibody E2 recognized and was specific for the MAP1B heavy chain. The same samples were
fractionated on a 17.5% gel. The resulting blot was cut into three horizontal segments. The segment containing proteins above 46 kD in
size was incubated with antitubulin antibodies for the detection of tubulin (Tb; internal control). The segment containing proteins from 20–
46 kD was incubated with the polyclonal anti–MAP1B light chain antibody (LC1). The segment containing proteins smaller than 20 kD
was incubated with antibody E2 as indicated for the detection of the 95 amino acid–long amino-terminal MAP1B fragment potentially en-
coded by exons 1 and 2 of the targeted allele with an expected size of 10 kD. No such amino-terminal fragment was detected. 
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In wild-type mice, MAP1B expression was widespread
during the formation of the retinal layers, but in contrast to
what had been reported for the rat (Hanley et al., 1999), it
was downregulated in the adult (Fig. 4). We used heavy
and light chain–specific antibodies that in rat retina pro-
duced results similar to those reported by Hanley et al.
(1999), and observed in mouse retina at postnatal day 9 a
distinct labeling of the inner plexiform layer (IPL) with a
concentration of MAP1B in several discrete bands and
staining in the outer nuclear layer (ONL; Fig. 4 A). In the
adult mouse retina, only weak and diffuse label was present
in the inner retina, while photoreceptors [inner segments
(IS), ONL] were labeled more prominently (Fig. 4 C). The
label, although diffuse, was specific, since by omitting the
primary antibody it was lost (Fig. 4 B). When retinae of
MAP1B 
 
2
 
/
 
2
 
 mice were immunostained for MAP1B, no
specific fluorescence was detectable (Fig. 4 D). Despite this
lack of MAP1B, the retinae of MAP1B-deficient mice did
not show morphological changes (Fig. 4). The retinal layer-
Figure 2. Expression of brain-specific MAPs other than MAP1B
in MAP1B-deficient mice. 80 mg of total protein extracted from
brains of wild-type (1/1), heterozygous (1/2) or homozygous
(2/2) MAP1B mutant mice of the indicated postnatal ages were
analyzed by immunoblotting using antibodies specific for the re-
spective proteins. Expression was not determined for MAP1A
heavy chain at day 1 or MAP1A light chain at day 49.
Figure 3. MAP1B-deficient mice lack exploring activity. Ex-
ploring activity of wild-type control mice (1/1) and mice ho-
mozygous (2/2) for the targeted MAP1B allele were tested for
exploring activity.
Figure 4. MAP1B expression in the mouse retina. (A) Fluores-
cence micrograph of a vertical section through a wild-type (1/1)
mouse retina at postnatal day P9 that was immunostained for
MAP1B. The inner plexiform layer is clearly labeled with a con-
centration of MAP1B in several discrete bands. MAP1B is also
expressed in the outer retina. (B) Vertical section through an
adult (1/1) mouse retina (postnatal day P47). In this control
micrograph, the primary antibody against MAP1B was omitted
and only nonspecific background label is detected. (C) Fluores-
cence micrograph of a vertical section through an adult (P47)
wild-type (1/1) mouse retina that was immunostained for
MAP1B. Diffuse, weak fluorescence is present in the inner ret-
ina, the outer retina is more intensely labeled. (D) Section
through a MAP1B-deficient (2/2) mouse retina that was im-
munostained for MAP1B. No specific label can be detected,
background intensity is identical to B. However, comparison of
D and C shows that the retinal layers are unchanged in the
MAP1B mutant mouse. IS, photoreceptor inner segments;
ONL, outer nuclear layer; OPL, outer plexiform layer; INL, in-
ner nuclear layer; GCL, ganglion cell layer. Bar, 50 mm.The Journal of Cell Biology, Volume 151, 2000 1174
ing and the cell densities appeared normal. We also immu-
nolabeled such retinae with markers that recognize specific
cell types in the mouse retina (Haverkamp, S., and H.
Wässle, unpublished results). Horizontal cells immunoreac-
tive for calbindin, amacrine cells immunoreactive for cal-
retinin, and bipolar cells immunoreactive for protein kinase
Cb appeared unchanged (not shown).
We next analyzed the expression and distribution of
GABAC receptors in wild-type and MAP1B-deficient
mice. GABAC receptors show a closely similar distribu-
tion in all mammalian retinae investigated (Wässle et al.,
1998). Consistent with these observations, we found that
in wild-type mice GABAC receptors were expressed by
rod and cone bipolar cells, including a low level of expres-
sion in their plasma membrane in the inner nuclear layer
(INL, Fig. 5 A). In the outer plexiform layer (OPL), GABAC
receptors were aggregated at the bipolar cell dendritic ter-
minals. In the IPL, strong, punctate immunofluorescence
was observed (Fig. 5, A and C). The distribution of puncta
in the IPL was not uniform, but horizontal bands of higher
and lower density of puncta were present. Electron mi-
croscopy has shown that the puncta (hot spots) represent a
clustering of GABAC receptors in postsynaptic densities
(Enz et al., 1996; Koulen et al., 1998). This clustering was
not perturbed in MAP1B-deficient mice (Fig. 5, compare
A and C with B and D). Comparison of the low power mi-
crographs (Fig. 5, A and B) showed that the label in the
OPL, INL, and IPL was identical between the control and
the MAP1B 2/2 retina. This was also true for the layer-
ing of the puncta in the IPL. The high-power micro-
graphs (Fig. 5, C and D) showed the distinct clustering of
the GABAC receptors indistinguishable in wild-type and
MAP1B mutant mice. This was quantified by counting the
number of puncta in vertical strips of 30-mm width through
the IPL and calculating their densities. In the (1/1)
mouse retina, the average density of GABAC immunore-
active hot spots was 34.3 6 2.8 (n 5 8) per 100 mm2. In the
(2/2) mouse retina, the average density was 36.4 6 2.8
(n 5 8). These results suggest that MAP1B is not the cru-
cial parameter in the clustering of GABAC receptors
at postsynaptic densities. We also found no change in
MAP1B-deficient mice in the clustering of GABAA recep-
tor subunits a1, a2, a3, and g2, the glycine receptors,
the glutamate receptor subunits GluR1, 4, and 6/7, the
N-methyl-D-arginine receptor subunits NR1C29 and NR2B,
and the postsynaptic density protein PSD-95 (not shown).
Agenesis of the Corpus Callosum in
MAP1B-deficient Mice
The neuropathological hallmark of MAP1B-deficient ani-
mals was agenesis of the corpus callosum. 80% of the ani-
mals with homozygous deletion of MAP1B (n 5 15) dis-
played total agenesis of the corpus callosum (Figs. 6 and 7).
In the parietal portions of the brain, the corpus callosum
was replaced by a fine fibrous membrane in which the chor-
oide plexus of the third ventricle was inserted. This mem-
brane was frequently lacking in more posterior portions of
the brain, where the third ventricle was found in direct con-
tinuity with the interhemispheric subarachnoid space. In
most animals, a longitudinal bundle of myelinated fibers
was found (Fig. 6, b, d, f, and h), resembling the Probst bun-
dle present in agenesis of the corpus callosum in humans
(Probst, 1901). It was located at the most medial parts of
the hemispheric white matter, traversing through the entire
hemisphere of the brain from the frontal to the occipital
lobe. The hemispheric cortex was normally developed, al-
though the gyrus cinguli was in part rotated ventrally. In
addition, prominent aberrant bundles of myelinated axons
were present in the deeper layers of the parietal cortex
Figure 5. GABAC receptor clus-
tering in MAP1B-deficient ret-
ina. (A) Section through a (1/1)
mouse retina that was immuno-
labeled for the GABAC recep-
tor subunits.  (B)  GABAC
receptor immunolabeling in
a( 2/2) mouse retina. (C)
High power micrograph of a
(1/1) mouse retina showing the
GABAC receptor synaptic clus-
ters in the IPL. (D) GABAC re-
ceptor synaptic clusters in the
IPL of a (2/2) mouse retina. IS,
photoreceptor inner segments;
ONL, outer nuclear layer; OPL,
outer plexiform layer; INL, in-
ner nuclear layer; GCL, gan-
glion cell layer. Scale bar: 55 mm
(A and B) and 20 mm (C and D).Meixner et al. MAP1B in Mouse Brain Development 1175
(Fig. 6, d and f). No astrocytic scaring was found in compar-
ison with normal wild-type animals (Fig. 6, i and j). The
hippocampi showed a regular cortical architecture, yet they
were dislocated laterally and the hippocampal commissure
was absent. In 20% of the homozygous animals, the devel-
opmental defect described above was incomplete. This was
either reflected by an unusually thin corpus callosum
throughout the whole brain or a lack of the corpus callo-
sum with similar abnormalities as described above, re-
stricted to the posterior portions of the forebrain.
The pathology of MAP1B-deficient animals was studied
on step serial sections of 0.1-mm distance covering the
whole brain and spinal cord. No other malformations were
found. In particular, other commissures, such as the com-
missura anterior, the commissura posterior, the commis-
sura habenularum, and the brain stem midline structures,
revealed no defects. No developmental abnormalities
were found in mice heterozygous for the MAP1B muta-
tion or in wild-type controls.
Peripheral Nerves in MAP1B-deficient Mice Have 
Axonal and Myelinization Defects Resulting in Reduced 
Motor Nerve Conduction Velocity
Histological and histomorphometrical assessment of the
sciatic nerves revealed a marked predominance of small-
caliber myelinated axons in MAP1B-deficient mice (Fig. 8
A). With the exception of axons in the 70- and 80-mm2
classes, numbers of axons in intermediate and large size
classes were reduced compared with wild-type controls, re-
sulting in a left shift of the size distribution histogram. In
addition, the myelin sheaths of axons of a given diameter
class had reduced thickness in MAP1B-deficient mice (Fig.
8 B). Concomitantly, the proportion of endoneural con-
nective tissue was increased, probably due to reduced axon
diameters, since we found no evidence for ongoing myelin
degeneration or myelinophagocytosis. The overall number
of axons appeared unchanged (2.93 6 0.31 3 104, n 5 3 in
wild-type controls, and 3.05 6 0.68 3 104, n 5 4 in homozy-
Figure 6. Agenesis of the corpus
callosum and formation of Probst
bundles in the brain of MAP1B-
deficient mice. (a, c, e, g, and i)
Frontal sections through the ce-
rebral white matter and corpus
callosum (CC) of a normal wild-
type mouse brain, showing nor-
mal architecture of myelinated fi-
ber tracts including the corpus
callosum (a, c, and e, blue), axons
(g, dark brown), and astrocytes
(i, brown). (b, d, f, h, and j) Cor-
responding brain region of a
homozygous MAP1B-deficient
mouse. The corpus callosum is
absent. The cerebral white mat-
ter ends medially in a thick bun-
dle of myelinated fibers (*Probst
bundle). Within the deeper lay-
ers of the cortex, thick bundles of
myelinated axons are visible (ar-
rowheads). Despite the massive
structural changes in the brain
tissue, there is no increase in re-
active astrocytes. CX, cerebral
cortex. (a–d) Luxol fast blue my-
elin stain; myelinated fiber tracts
such as the corpus callosum are
stained blue, areas of grey matter
are stained red, 403. (e and f)
Luxol fast blue myelin stain,
1203. (g and h) Bielschowski sil-
ver impregnation; axons within
fiber tracts are stained black, ar-
eas of grey matter reveal light
brown staining, 1203. (i and j)
Immunocytochemistry for glial
fibrillary acidic protein; astro-
cytes containing glial fibrillary
acidic protein are stained brown.
Cellular nuclei of the tissue are
counterstained with hematoxylin
blue, 1203.The Journal of Cell Biology, Volume 151, 2000 1176
gous mutants). Consistent with this observation, motor
nerve conduction velocity was reduced to 19.82 6 2.93
(mean 6 SD, n 5 8) in homozygous mutants compared
with 30.60 6 6.71 (mean 6 SD, n 5 16) in wild-type con-
trols. None of the conduction velocities of the homozygous
animals was within 1 SD of the values observed in wild-
type mice. The difference in conduction velocities between
controls and homozygotes was statistically significant (P ,
0.05) when compared with one way analysis of variance.
Discussion
Mice Homozygous for MAP1BD93 Are the First True 
MAP1B-deficient Mice
By deleting 93% of the coding capacity of the MAP1B
gene, we have generated a true null allele, MAP1BD93,
and, in contrast to the two previous MAP1B gene-target-
ing studies (Edelmann et al., 1996; Takei et al., 1997), were
able to assess for the first time the effects of MAP1B defi-
ciency on the development of the murine nervous system.
The previous MAP1B targeting studies produced incon-
clusive and contradictory results. The targeting strategy
employed by Takei et al. (1997) reduced MAP1B to z5%
Figure 7. Schematic representation of brain areas shown in Fig. 6.
(Top) Side view of the rodent brain (sagittal section). The locations
of the frontal sections shown in Fig. 6, a and b and c and d, are indi-
cated by vertical lines labeled a,b and c,d, respectively. CB, cerebel-
lum. (Middle and bottom) Schematic representation of the frontal
sections shown in Fig. 6, a and b (a,b) and c and d (c,d). The left side
of the brain in each schematic shows the normal situation, the right
side the changes in MAP1B-deficient animals. In the normal brain,
nerve fibers insert into the corpus callosum (CC) and cross the mid-
line. In MAP1B-deficient animals, these fibers do not cross the mid-
line (indicated by the X), but form a thick bundle of fibers that runs
in the longitudinal direction of the brain (PB, Probst bundle). In ad-
dition, thick aberrant fiber bundles leave the centrum semiovale
and enter the basal layers of the cortex, where they turn by 908 and
further traverse in parallel to the cortical surface (*). The rectangles
in the middle and bottom panels delineate the areas shown in Fig. 6,
a and b and c and d, respectively. CX, cerebral cortex.
Figure 8. Predominance of small myelinated nerve fibers (A)
and reduced thickness of myelin sheaths (B) in the sciatic nerve
of MAP1B-deficient mice. Sciatic nerve preparations from three
wild-type and four MAP1B-deficient mice were used to obtain
the data. (A) The size distribution of axon areas differed signifi-
cantly (Kolmogoroff-Smirnoff test, P , 0.001) between MAP1B-
deficient (n 5 465) and wild-type (n 5 206) sciatic axons. (B) My-
elin sheath thickness was assessed from axons with areas ,10 mm
(MAP1B 2/2, n 5 265, vs. wild-type, n 5 66). *The mean values
of the myelin sheath thickness were significantly smaller (t test,
P , 0.001) in MAP1B 2/2 mice (1.11 6 0.36 mm) compared with
wild-type animals (1.70 6 0.57 mm).Meixner et al. MAP1B in Mouse Brain Development 1177
of its normal level, but did not result in complete ablation
of MAP1B expression. Not surprisingly, homozygous mu-
tants merely displayed a transient retardation in develop-
ment and did not reveal the effects of true MAP1B defi-
ciency, a caveat also limiting the significance of their
recent results obtained in MAP1B/tau double knockout
mice in which they used the same incompletely inactivated
MAP1B allele (Takei et al., 2000).
Contradictory to the results obtained by Takei et al.
(1997), Edelmann et al. (1996) reported that mice homozy-
gous for a MAP1B allele termed MAP1B571 (which is inter-
rupted at codon 571 by a stop codon) died in early embry-
onic development and 20% of mice heterozygous for
MAP1B571 (which still expressed MAP1B from the intact
allele) displayed ataxia and spastic tremor and abnormali-
ties in the cerebellum. At present, it is not clear why the phe-
notype of MAP1B571 was so severe. One possibility is that
the severity is influenced by the genetic background on
which this mutation was introduced. In contrast to the mice
generated in the present study, one component of the back-
ground of MAP1B571 mice was derived from 129P2/Ola, a
strain displaying axonal guidance problems and defects in
brain development in wild-type mice (Wahlsten, 1982). It is
conceivable that the additional reduction or ablation of
MAP1B expression on this background lead to severe de-
velopmental problems. A second likely factor that might
limit analysis of MAP1B function in knockout mice of Edel-
mann et al. (1996) is the potential expression of the 571
amino acid amino-terminal MAP1B fragment encoded by
the targeted allele. This fragment might have dominant-neg-
ative activity (Tögel et al., 1998), resulting in the dominant
phenotypes observed in mice heterozygous for MAP1B571.
Here we generated MAP1BD93, an allele carrying a de-
letion of most of the MAP1B gene. This deletion pre-
vented synthesis of MAP1B from regular as well as al-
ternative transcripts, resulted in complete ablation of
MAP1B heavy chain and light chain expression, prevented
the expression of amino-terminal MAP1B fragments, did
not lead to dominant alterations in heterozygous mutants,
and was analyzed on a genetic background permissive to
complete MAP1B deficiency.
MAP1B Is Required for Axon Guidance
By generating true MAP1B-deficient mice, we were able
to demonstrate that MAP1B was required for axon guid-
ance in a subset of neurons during brain development.
Histological examination of homozygous MAP1B mutant
mice revealed a specific developmental brain defect, agen-
esis of the corpus callosum, and the formation of Probst
bundles (Probst, 1901). In addition, we found prominent
aberrant growth of fibers in thick bundles, located in the
lower layers of the cortex. This may suggest that callosal fi-
bers, which are unable to cross the midline, still are at least
in part targeted to cortical regions, albeit on the ipsilateral
side. Agenesis of the corpus callosum has been observed in
some inbred strains of mice and is also influenced by rear-
ing conditions (Wahlsten, 1982). However, in the present
study, agenesis of the corpus callosum and the formation
of Probst bundles strictly correlated with the MAP1B ge-
notype and was observed in all mice homozygous for the
MAP1B deletion, but never in heterozygous mutants or
wild-type controls, demonstrating that MAP1B is essential
for corpus callosum formation.
Despite the fact that MAP1B is expressed in axons, den-
drites, and growth cones throughout the central nervous
system during development, the axonal guidance defect is
limited to the corpus callosum and the hippocampal com-
missure. One possible explanation for this specificity is
that redundant backup mechanisms exist for the guidance
of most axons, whereas corpus callosum formation is criti-
cally dependent on all components of a single mechanism.
MAP1B might be a component of a signal transduction
pathway guiding axons across an environment determined
by midline glia cells. These cells express laminin on their
cell surface (Liesi and Silver, 1988) and it has been shown
that MAP1B is necessary for laminin-enhanced axonal
growth in vitro (DiTella et al., 1996). In addition, callosal
axon guidance defects are observed in mice lacking the
cdk5 activator p35 (Kwon et al., 1999), a protein impli-
cated in regulation of laminin-induced MAP1B phos-
phorylation (Paglini et al., 1998). Thus, MAP1B might be
involved in laminin/integrin-mediated cell adhesion and/or
signaling and this pathway could be crucial for corpus cal-
losum formation. Likewise, MAP1B, capable of binding to
actin fibers (Pedrotti and Islam, 1996; Tögel et al., 1998),
might be involved in the regulation of actin polymeriza-
tion in the growth cone by the netrin/MENA pathway,
which is also involved in corpus callosum formation
(Serafini et al., 1996; Fazeli et al., 1997; Lanier et al.,
1999). Involvement of MAP1B in laminin or netrin signal-
ing might not be mutually exclusive, since laminin and ne-
trin share structural homologies (Serafini et al., 1996).
An alternative explanation for the selective defect in
MAP1B-deficient brains might be that midline crossing of
callosal fibers is limited to a temporal window. If callosal
axons were to be slowed down in their progress towards
the midline as a result of MAP1B deficiency, they might
miss the permissive window and, instead of crossing, ex-
tend parallel to the midline or turn back. In this context, it
is of interest that a Drosophila MAP termed Futsch is nec-
essary for axonal growth and extension (Hummel et al.,
2000). Futsch is quite distinct from any of the vertebrate
MAPs, but shares two stretches of sequence homology
with MAP1B and MAP1A.
MAP1B Is Required for Development and Function of 
the Peripheral Nervous System
In contrast to the previous MAP1B targeting studies, we
were able to demonstrate that MAP1B deficiency lead to
permanent defects in the peripheral nervous system. Mor-
phometric analysis revealed that the axons constituting the
adult sciatic nerve of MAP1B-deficient mice were of de-
creased diameters and that the thickness of myelin sheaths
of the remaining axons was reduced. Electrophysiological
measurements in the sciatic nerve showed a reduction
in conductance velocities in MAP1B-deficient mice by
z35%, consistent with the observed alterations in axon di-
ameter and myelin sheaths. Thus, our findings extend ob-
servations of Takei et al. (1997), who reported that reduc-
tion of MAP1B expression leads to a delay in myelination
in the optic nerve. The reduction in numbers of large my-
elinated axons observed in our mice is likely to be due to
the failure of most MAP1B-deficient axons to grow to
larger diameters and not to a selective loss of large-caliber
axons in the adult, since we were unable to observe any
signs of axon-degeneration and the numbers of axons perThe Journal of Cell Biology, Volume 151, 2000 1178
sciatic nerve did not significantly differ in wild-type and
homozygous mutant mice. The reduction in the thickness
of myelin sheaths could possibly be due to the lack of
MAP1B in Schwann cells and/or the corresponding axons
during the process of myelination. Both Schwann cells and
axons contain MAP1B (Fawcett et al., 1994; Bush et al.,
1996b; Ramón-Cueto and Avila, 1997).
MAP1B Is Not Essential for Retina Development and 
GABAC Receptor Clustering
The recent finding that MAP1B interacts with the cyto-
plasmic domain of the retina-specific GABAC receptor
subunit  r1 has lead to the hypothesis that MAP1B belongs
to a family of synapse-associated proteins that are in-
volved in clustering ion channels at postsynaptic sites pro-
viding a link to the cytoskeleton and possibly contributing
to the regulation of synaptic efficacy by electrical activity
(Hanley et al., 1999). In contrast to previous MAP1B tar-
geting studies, the generation of a true null allele of
MAP1B allowed us to address the question of whether
MAP1B was indeed essential for retina development and
GABAC receptor clustering. If this were the case, one
would expect an absence of GABAC immunoreactive
puncta, or at least a reduction of their density, in the
MAP1B-deficient mouse retina. However, we found no
difference in the pattern of GABAC staining between
MAP1B-deficient and wild-type mice. Whereas our results
do not rule out that MAP1B participates in receptor clus-
tering and linkage to the cytoskeleton, they do demon-
strate that MAP1B does not play an essential role in
GABAC receptor clustering.
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